Presentation is loading. Please wait.

Presentation is loading. Please wait.

CVM Communications Presented by Laura Alvey Deputy Director, Office of Communications Center for Veterinary Medicine Risk Communication Advisory Committee.

Published byKarin Montgomery Modified over 8 years ago

Similar presentations

Presentation on theme: "CVM Communications Presented by Laura Alvey Deputy Director, Office of Communications Center for Veterinary Medicine Risk Communication Advisory Committee."— Presentation transcript:

1 CVM Communications Presented by Laura Alvey Deputy Director, Office of Communications Center for Veterinary Medicine Risk Communication Advisory Committee Meeting Rockville, Maryland August 14, 2008

2 Center for Veterinary Medicine Challenges ► CVM is the smallest of FDA Centers ► Regulates a wide range of products such as animal drugs, cloning, genetically engineered animals, BSE, growth hormones for animals and medicated/non- medicated feed (includes pet food) ► Much of the public and even industry not familiar with CVM

3 Non-Persuasive-Informative Communication ► CVM Website (brochures) –NSAIDS for Dogs –Cloning –Pet Food ► Newsletter – FDA and the Veterinarian ► Annual Report ► CVM Update ► Consumer Articles ► Exhibits ► Public Meetings

4 Persuasive Communication ►Recall Notices ►Warning Letters ►Untitled Letters

5 Persuasive Communication Criteria What Do We Consider? ►Surveillance ►Look for trends/patterns in reports ►How confident are we in the information? ►What is the potential for public harm? ►Risk/Benefit ratio ►Typically targeted towards industry

6 How Can We Best Serve Our Stakeholders (consumers, Veterinarians, Animal Healthcare Producers, Feed Industry, Etc.) in Providing Timely and Important Information? ► What vehicle (web, radio, TV, print, etc.) provides the optimum exposure? ► Does the target audience determine the type of document/product? ► How can outside groups participate in disseminating our message?

7 Persuasive/Non-persuasive Communication Challenges ►How do we balance the need to communicate early while issues are still emerging without causing undue alarm or damage to a business or industry? ►What are the best techniques for conveying an “emerging and/or uncertain issue”? ►How do you practice follow-up as the issue unfolds, i.e. how often do you communicate, how do you come to closure, etc?

Download ppt "CVM Communications Presented by Laura Alvey Deputy Director, Office of Communications Center for Veterinary Medicine Risk Communication Advisory Committee."

Similar presentations

NCPIE CMI Initiative. Education Committee Members American Pharmacists Association First DataBank National Assn. of Boards of Pharmacy National Assn.

NCPIE CMI Initiative. Education Committee Members American Pharmacists Association First DataBank National Assn. of Boards of Pharmacy National Assn.
Bovine Spongiform Encephalopathy (BSE) in Canada Pedro Piccardo, MD Division of Emerging and Transfusion-Transmitted Diseases Office of Blood Research.

Bovine Spongiform Encephalopathy (BSE) in Canada Pedro Piccardo, MD Division of Emerging and Transfusion-Transmitted Diseases Office of Blood Research.
Dr. Michael E. Oehlsen International Policy Analyst International Programs Team - Office of the Director Center for Veterinary Medicine Food and Drug Administration.

Dr. Michael E. Oehlsen International Policy Analyst International Programs Team - Office of the Director Center for Veterinary Medicine Food and Drug Administration.
FEED and FERTILIZER INSPECTORS SEMINAR TEXAS FEED and FERTILIZER CONTROL SERVICE REGULATORY PROGRAM and ANNUAL WORK PLAN Presenter: Curtis Hinton.

FEED and FERTILIZER INSPECTORS SEMINAR TEXAS FEED and FERTILIZER CONTROL SERVICE REGULATORY PROGRAM and ANNUAL WORK PLAN Presenter: Curtis Hinton.
FDA and Communication about Regulated Products Nancy M. Ostrove, PhD Senior Advisor for Risk Communication Risk Communication Advisory Committee August.

FDA and Communication about Regulated Products Nancy M. Ostrove, PhD Senior Advisor for Risk Communication Risk Communication Advisory Committee August.
Objectives Why we need DHCPL Situations that call for a DHCPL Definitions DHCPL itself–content, presentation, process Target audience Current and future.

Objectives Why we need DHCPL Situations that call for a DHCPL Definitions DHCPL itself–content, presentation, process Target audience Current and future.
Canine NSAIDs—What Dog Owners Should Know

Canine NSAIDs—What Dog Owners Should Know
Vernon D. Toelle, Ph.D. Team Leader Pre-Market Compliance and Administrative Actions Team (BIMO Team) Overview of CVM Bioresearch Monitoring.

Vernon D. Toelle, Ph.D. Team Leader Pre-Market Compliance and Administrative Actions Team (BIMO Team) Overview of CVM Bioresearch Monitoring.
Ohio Nano-Summit March 3, 2005 REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D. Associate.

Ohio Nano-Summit March 3, 2005 REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D. Associate.
Protecting and Promoting Your Health How this work supports FDA’s mission: TO PROMOTE HUMAN and ANIMAL HEALTH by collaborating with veterinary diagnostic.

Protecting and Promoting Your Health How this work supports FDA’s mission: TO PROMOTE HUMAN and ANIMAL HEALTH by collaborating with veterinary diagnostic.
Dr. Patty Bennett Deputy Director, Science Staff Office of Public Health Science Food Safety and Inspection Service National Residue Program Food Safety.

Dr. Patty Bennett Deputy Director, Science Staff Office of Public Health Science Food Safety and Inspection Service National Residue Program Food Safety.
Center for Veterinary Medicine (CVM) RECALLS.  21 CFR 7.40 provides guidance on the policy, procedures, and industry responsibilities for recalls. 

Center for Veterinary Medicine (CVM) RECALLS.  21 CFR 7.40 provides guidance on the policy, procedures, and industry responsibilities for recalls. 
Physiologists & the FDA Kevin J. Greenlees, Ph.D., DABT Senior Advisor for Science & Policy Office of New Animal Drug Evaluation FDA Center for Veterinary.

Physiologists & the FDA Kevin J. Greenlees, Ph.D., DABT Senior Advisor for Science & Policy Office of New Animal Drug Evaluation FDA Center for Veterinary.
Improved Bergen County Process for: Communicating the Value of County-level and Local-Contract health Services provided by the Dept. Committee of selected.

Improved Bergen County Process for: Communicating the Value of County-level and Local-Contract health Services provided by the Dept. Committee of selected.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
FDA Science Board Drug Safety Initiative April 15, 2005 Rockville, MD RADM Steven Galson, MD, MPH Acting Director, Center for Drug Evaluation and Research.

FDA Science Board Drug Safety Initiative April 15, 2005 Rockville, MD RADM Steven Galson, MD, MPH Acting Director, Center for Drug Evaluation and Research.
Industry Update NZFMA Seminar, Wellington 19 March 2014 Michael Brooks Executive Director.

Industry Update NZFMA Seminar, Wellington 19 March 2014 Michael Brooks Executive Director.
Revision of Canada’s Food Guide to Healthy Eating

Revision of Canada’s Food Guide to Healthy Eating
Drug Transfer Into Breast Milk and Interpretation of Data Lawrence J. Lesko Office of Clinical Pharmacology and Biopharmaceutics Center for Drug Evaluation.

Drug Transfer Into Breast Milk and Interpretation of Data Lawrence J. Lesko Office of Clinical Pharmacology and Biopharmaceutics Center for Drug Evaluation.
NSF International Overview. NSF International Established in 1944, as the National Sanitation Foundation, (University of Michigan Professors), a standards.

NSF International Overview. NSF International Established in 1944, as the National Sanitation Foundation, (University of Michigan Professors), a standards.

Similar presentations

Ads by Google